Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Jan Medical

Request full access

Theme designers with lovely barnets.

Mountain View, United StatesFounded 2003Biotech & Life Sciences

About Jan Medical

Jan Medical, founded in 2003 by serial entrepreneur Dr. Paul Lovoi, is a medical technology company focused on developing non-invasive systems for diagnosing and monitoring abnormal neurological conditions. The inspiration for the company stemmed from a personal tragedy in Dr. Lovoi's life; his wife, Jan, suffered a fatal subarachnoid hemorrhagic stroke, motivating him to find a better, less invasive method for neurodiagnostics. With a Ph.D. in physics and extensive experience in Silicon Valley startups, Dr. Lovoi applied principles from submarine signal processing to brain monitoring, leading to the development of the company's core technology.

The company operates in the medical device market, specifically targeting healthcare professionals in hospital, athletic, and military settings. Jan Medical's business revolves around the development and eventual commercialization of its proprietary diagnostic tools, with revenue streams expected from the sale of these devices. The company has secured significant funding to support its research, clinical trials, and regulatory approval processes. Over three rounds, it raised a total of $11M, with a notable Series C funding of $7.5 million in January 2016 led by medical technology firm Brainlab. This strategic partnership also provides Jan Medical with resources for clinical research, regulatory filings, and commercialization activities.

Jan Medical's primary product is the BrainPulse™ system (formerly known as Nautilus NeuroWave), a portable, non-invasive brain-sensing device. The system comprises a headset equipped with six accelerometers and a heart rate sensor, a data collector, and a computer with a touchscreen tablet interface. It functions by using the heart's cardiac output to measure the pulsatile motion of the brain, allowing for the detection of changes in vasculature and brain tissue conditions. This technology is designed to serve as a rapid diagnostic aid for conditions such as ischemic stroke, concussion, and cerebral vasospasm, with a typical recording taking only three to five minutes. The BrainPulse has received de novo clearance from the FDA as a class II device for cranial motion measurement, and the company is actively pursuing further FDA approvals for specific diagnostic indications.

Source: Dealroom company data

Jan Medical in the Mountain View ecosystem

Live from Dealroom

The Jan Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Brainlab
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Mountain View HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Jan Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Jan Medical on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.